63 related articles for article (PubMed ID: 6329460)
1. Effects of insulin, insulin-like growth factor-II and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells.
Recio-Pinto E; Ishii DN
Brain Res; 1984 Jun; 302(2):323-34. PubMed ID: 6329460
[TBL] [Abstract][Full Text] [Related]
2. An appropriate ratio of unsaturated fatty acids is the constituent of hickory nut extract for neurite outgrowth in human SH-SY5Y cells.
Gao F; Wu J; Zhou Y; Huang J; Lu J; Qian Y
Food Sci Nutr; 2020 Dec; 8(12):6346-6356. PubMed ID: 33312521
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial quality control system: a new target for exercise therapeutic intervention in the treatment of brain insulin resistance-induced neurodegeneration in obesity.
Cai M; Wan J; Cai K; Li S; Du X; Song H; Sun W; Hu J
Int J Obes (Lond); 2024 Jun; 48(6):749-763. PubMed ID: 38379083
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms mediating the impact of maternal obesity on offspring hypothalamic development and later function.
Furigo IC; Dearden L
Front Endocrinol (Lausanne); 2022; 13():1078955. PubMed ID: 36619540
[TBL] [Abstract][Full Text] [Related]
5. Tissue-Engineered Models of the Human Brain: State-of-the-Art Analysis and Challenges.
Tarricone G; Carmagnola I; Chiono V
J Funct Biomater; 2022 Sep; 13(3):. PubMed ID: 36135581
[TBL] [Abstract][Full Text] [Related]
6. Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia.
Hufnagel A; Dearden L; Fernandez-Twinn DS; Ozanne SE
J Endocrinol; 2022 Apr; 253(2):R47-R63. PubMed ID: 35258482
[TBL] [Abstract][Full Text] [Related]
7. Temporal Proteomic Profiling of SH-SY5Y Differentiation with Retinoic Acid Using FAIMS and Real-Time Searching.
Zhang T; Gygi SP; Paulo JA
J Proteome Res; 2021 Jan; 20(1):704-714. PubMed ID: 33054241
[TBL] [Abstract][Full Text] [Related]
8. Maternal obesity causes fetal hypothalamic insulin resistance and disrupts development of hypothalamic feeding pathways.
Dearden L; Buller S; Furigo IC; Fernandez-Twinn DS; Ozanne SE
Mol Metab; 2020 Dec; 42():101079. PubMed ID: 32919096
[TBL] [Abstract][Full Text] [Related]
9. Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity.
Bouret S; Levin BE; Ozanne SE
Physiol Rev; 2015 Jan; 95(1):47-82. PubMed ID: 25540138
[TBL] [Abstract][Full Text] [Related]
10. Effects of valproic Acid on axonal regeneration and recovery of motor function after peripheral nerve injury in the rat.
Rao T; Wu F; Xing D; Peng Z; Ren D; Feng W; Chen Y; Zhao Z; Wang H; Wang J; Kan W; Zhang Q
Arch Bone Jt Surg; 2014 Mar; 2(1):17-24. PubMed ID: 25207308
[TBL] [Abstract][Full Text] [Related]
11. Insulin blocks glutamate-induced neurotoxicity in differentiated SH-SY5Y neuronal cells.
Nampoothiri M; Reddy ND; John J; Kumar N; Kutty Nampurath G; Rao Chamallamudi M
Behav Neurol; 2014; 2014():674164. PubMed ID: 25018588
[TBL] [Abstract][Full Text] [Related]
12. Optimising parameters for the differentiation of SH-SY5Y cells to study cell adhesion and cell migration.
Dwane S; Durack E; Kiely PA
BMC Res Notes; 2013 Sep; 6():366. PubMed ID: 24025096
[TBL] [Abstract][Full Text] [Related]
13. A brain-specific Grb2-associated regulator of extracellular signal-regulated kinase (Erk)/mitogen-activated protein kinase (MAPK) (GAREM) subtype, GAREM2, contributes to neurite outgrowth of neuroblastoma cells by regulating Erk signaling.
Taniguchi T; Tanaka S; Ishii A; Watanabe M; Fujitani N; Sugeo A; Gotoh S; Ohta T; Hiyoshi M; Matsuzaki H; Sakai N; Konishi H
J Biol Chem; 2013 Oct; 288(41):29934-42. PubMed ID: 24003223
[TBL] [Abstract][Full Text] [Related]
14. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.
Kovalevich J; Langford D
Methods Mol Biol; 2013; 1078():9-21. PubMed ID: 23975817
[TBL] [Abstract][Full Text] [Related]
15. Insulin and insulin-like growth factor prevent brain atrophy and cognitive impairment in diabetic rats.
Serbedžija P; Ishii DN
Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 3):S601-10. PubMed ID: 23565496
[TBL] [Abstract][Full Text] [Related]
16. Insulin in the brain: sources, localization and functions.
Ghasemi R; Haeri A; Dargahi L; Mohamed Z; Ahmadiani A
Mol Neurobiol; 2013 Feb; 47(1):145-71. PubMed ID: 22956272
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.
Kim H; Kim JJ; Yoon YS
Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):168-78. PubMed ID: 22236028
[TBL] [Abstract][Full Text] [Related]
18. Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes.
Serbedzija P; Madl JE; Ishii DN
Brain Res; 2009 Dec; 1303():179-94. PubMed ID: 19781531
[TBL] [Abstract][Full Text] [Related]
19. Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis.
Levin BE
Philos Trans R Soc Lond B Biol Sci; 2006 Jul; 361(1471):1107-21. PubMed ID: 16815795
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.
Garcia de Yebenes J; Yebenes J; Mena MA
Neurotox Res; 2000; 2(2-3):115-37. PubMed ID: 16787836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
